World Forum on Interventional Psychiatry, Neuromodulation & Neuroplastic Therapeutics
An international clinical and translational assembly evaluating accelerated transcranial magnetic stimulation (SAINT/aiTBS protocols), rapid-acting neuroplastogens, and closed-loop deep brain interfaces across hospital psychiatric departments and university academic centers.
Practice Framework & Colloquium Charter
Biological and interventional psychiatry is experiencing a fundamental clinical transition driven by targeted neuromodulation and rapid-acting neurotherapeutics. While pharmacoresistant depression (TRD), severe obsessive-compulsive disorder (OCD), and acute suicidal crises historically presented major clinical endpoints with limited acute pharmacotherapies, emerging technologies offer rapid symptom mitigation.
The World Forum on Interventional Psychiatry, Neuromodulation & Neuroplastic Therapeutics (MindNeuro 2027) convenes hospital medical directors, academic psychiatrists, clinical neurophysiologists, and psychopharmacology investigators to evaluate multicenter clinical trial readouts, individualized fMRI stereotactic coil targeting, and inpatient implementation economics.
Core clinical objectives focus on establishing hospital-grade safety protocols for accelerated theta-burst stimulation (SAINT/aiTBS), resolving real-world durability questions for sub-anesthetic esketamine maintenance programs, and standardizing closed-loop intracranial electrophysiological biomarkers for deep brain stimulation.
Academic Governance & Ethics
- Abstracts evaluated under a double-blind peer-review protocol complying with the Declaration of Helsinki research ethics charter.
- Direct editorial determinations communicated within 10 business days of submission.
- Commercial firewall strictly separates industry educational grants from scientific abstract selections and podium allocations.
- Structured floor critique and question-and-answer periods integrated into every didactic plenary defense.
Five Peer-Reviewed Scientific & Clinical Tracks
Accelerated TMS Protocols & Stereotactic Targeting
- Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT / aiTBS) trial durability.
- Individualized resting-state functional connectivity fMRI neuronavigation.
- Bilateral DLPFC, dmPFC, and orbitofrontal montage optimization in TRD and OCD.
- Theta-burst coil physics, electric-field modeling, and depth penetration kinetics.
Neuroplastogens, Ketamine & Receptor Pharmacology
- Sub-anesthetic IV ketamine vs. intranasal esketamine long-term safety and taper protocols.
- NMDA receptor antagonism and downstream mTORC1-mediated synaptogenesis.
- AMPA receptor potentiators and non-hallucinogenic psychoplastogen synthesis.
- Mitigating dissociative, hemodynamic, and cystitis side-effect profiles in clinical populations.
Closed-Loop Deep Brain Stimulation & Vagus Nerve Stimulation
- Ventral capsule/ventral striatum (VC/VS) and subcallosal cingulate (SCC) DBS for refractory depression.
- Adaptive, sensing-enabled closed-loop neurostimulation using local field potentials (LFPs).
- Surgical and non-invasive transcutaneous auricular vagus nerve stimulation (taVNS).
- Autonomic tone modulation and neuroinflammatory biomarker mitigation.
Objective Biomarkers: EEG Microstates & Neuroimaging
- Default Mode Network (DMN) vs. Central Executive Network (CEN) functional connectivity shifts.
- High-density quantitative EEG microstate dynamics predicting rapid treatment response.
- Machine-learning stratification of psychiatric biotypes to guide neuromodulation modality selection.
- Digital phenotyping and sensor-based monitoring of relapse in treatment-resistant cohorts.
Hospital Interventional Suites & Practice Economics
- Designing, staffing, and managing inpatient acute suicide-risk interventional psychiatric suites.
- European health service coding, insurance reimbursement, and health economic cost-effectiveness.
- Clinical safety protocols, nursing credentialing, and post-intervention monitoring standards.
- Harmonizing EMA and international clinical guidelines for rapid-acting psychiatric interventions.
Electroconvulsive Therapy (ECT) Optimization & Cognitive Preservation
- Ultra-brief pulse right unilateral (RUL) dosing algorithms vs. accelerated rTMS non-inferiority trials.
- Anesthetic selection (etomidate, propofol, ketamine adjuvant) and seizure adequacy parameters.
- Objective neurocognitive monitoring protocols to eliminate persistent retrograde amnesia.
Two-Day Assembly Timetable (Paris Local Time / CET)
Day 01: Wednesday, April 21, 2027 • Accelerated Stimulation & Pharmacology
| Time (CET) | Curriculum Component & Academic Session |
|---|---|
| 08:00 – 08:45 | Registration Desk Open: Delegate credential verification and materials collection. |
| 08:45 – 09:15 | Opening Plenary Address: Welcome by Assembly Chairs & Declaration of Helsinki compliance charter. |
| 09:15 – 11:00 | Track 01 Plenary Session: Accelerated TMS (aiTBS / SAINT protocols), coil physics, and targeting precision. |
| 11:00 – 11:30 | Morning Concourse Break: Moderated poster presentations & scientific concourse exhibits. |
| 11:30 – 13:00 | Track 02 Plenary Session: Rapid-acting neuroplastogens, esketamine maintenance, and synaptogenesis kinetics. |
| 13:00 – 14:00 | Faculty Luncheon: Bilateral academic networking and institutional roundtable discussions. |
| 14:00 – 16:30 | Track 03 Plenary Session: Deep brain stimulation, closed-loop electrophysiology, and vagal nerve interfaces. |
| 16:30 – 17:30 | Floor Defense & Critiques: Clinical question-and-answer session with primary trial investigators. |
Day 02: Thursday, April 22, 2027 • Biomarkers, Clinical Economics & Protocols
| Time (CET) | Curriculum Component & Academic Session |
|---|---|
| 08:30 – 09:00 | Keynote Monograph: Neurocircuitry remodeling and long-term durability in pharmacoresistant depression. |
| 09:00 – 11:00 | Track 04 Plenary Session: Quantitative EEG microstates, resting-state fMRI, and machine learning biotypes. |
| 11:00 – 11:30 | Midday Concourse Break: Author poster defenses and research collaborations. |
| 11:30 – 13:00 | Track 05 Plenary Session: Designing and operationalizing inpatient hospital interventional psychiatric suites. |
| 13:00 – 14:00 | Faculty Luncheon: Trainee-faculty interactions and international collaborative study planning. |
| 14:00 – 15:45 | Late-Breaking Clinical Trial Readouts: Multi-center Phase II/III interventional psychiatric datasets. |
| 15:45 – 16:30 | Academic Valedictory & Credential Issuance: Distribution of official 14.5 Educational Contact Hour Certificates. |
Call for Proffered Papers & Abstract Guidelines
Submission Criteria for Oral & Poster Presentations
The Scientific Steering Committee invites original research submissions across clinical trials, translational laboratory studies, neuroimaging investigations, and health economic evaluations in interventional psychiatry.
Accepted submissions will be categorized by the review board as either a 15-Minute Plenary Oral Podium Defense or an Assigned Concourse Scientific Poster Board. Accepted abstracts are published in the official symposium compendium.
Colloquium Pass Schedule & Institutional Fees
Clinical Delegate Pass
For consultant psychiatrists, medical directors, and university faculty attending to evaluate clinical data and claim 14.5 Educational Contact Hours.
Presenting Author Pass
Subsidized rate for investigators presenting an accepted oral podium defense or scientific poster board. Includes proceedings publication.
Resident & Fellow Pass
Subsidized rate for psychiatric residents, clinical fellows, and doctoral trainees. Department verification letter required.
Virtual Technical Pass
Full synchronous live stream access, electronic e-poster compendium, interactive text Q&A, and electronic CME certificate issuance.
Industry Technical Support & Educational Grants
MindNeuro 2027 provides an ethical, compliance-certified environment for medical device manufacturers, TMS developers, and clinical-stage neuropharmaceutical organizations to engage with hospital department heads and trial directors.
Lead Category Educational Partner
Includes an exclusive 25-minute morning plenary keynote address, 10 guaranteed 1-on-1 private buyer meetings with hospital psychiatry chairs, category exclusivity, and 4 VIP passes.
Strategic Briefing Partner
Features a 15-minute scientific technology spotlight in Track 01 (TMS) or Track 02 (Neuroplastogens), 6 pre-scheduled bilateral briefings with clinical PIs, and a turnkey concourse station.
Turnkey Matchmaking Host
An executive foyer meeting post in the primary networking concourse with 4 pre-qualified 1-on-1 meetings arranged by the Secretariat with clinical trial purchasing leads.